Imatinib increases cytotoxicity of melphalan and their combination allows an efficient killing of chronic myeloid leukemia cells.
about
Mesenchymal Stem Cells (MSC) Regulate Activation of Granulocyte-Like Myeloid Derived Suppressor Cells (G-MDSC) in Chronic Myeloid Leukemia PatientsRaf/MEK/ERK signaling inhibition enhances the ability of dequalinium to induce apoptosis in the human leukemic cell line K562.Monocytic myeloid-derived suppressor cells as prognostic factor in chronic myeloid leukaemia patients treated with dasatinib.Development of an assay for cellular efflux of pharmaceutically active agents and its relevance to understanding drug interactions.
P2860
Imatinib increases cytotoxicity of melphalan and their combination allows an efficient killing of chronic myeloid leukemia cells.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Imatinib increases cytotoxicit ...... hronic myeloid leukemia cells.
@en
Imatinib increases cytotoxicit ...... hronic myeloid leukemia cells.
@nl
type
label
Imatinib increases cytotoxicit ...... hronic myeloid leukemia cells.
@en
Imatinib increases cytotoxicit ...... hronic myeloid leukemia cells.
@nl
prefLabel
Imatinib increases cytotoxicit ...... hronic myeloid leukemia cells.
@en
Imatinib increases cytotoxicit ...... hronic myeloid leukemia cells.
@nl
P2093
P2860
P50
P921
P1476
Imatinib increases cytotoxicit ...... chronic myeloid leukemia cells
@en
P2093
Concetta Conticello
Nunziatina Parrinello
Piera La Cava
Vittorio Del Fabro
P2860
P304
P356
10.1111/J.1600-0609.2010.01570.X
P50
P577
2011-02-08T00:00:00Z